EconPapers    
Economics at your fingertips  
 

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

Antonio J. Trujillo (), Jose C. Gutierrez (), Emmanuel E. Garcia Morales (), Mariana Socal (), Jeromie Ballreich () and Gerard Anderson ()
Additional contact information
Antonio J. Trujillo: Bloomberg School of Public Health, Johns Hopkins University
Jose C. Gutierrez: Bloomberg School of Public Health, Johns Hopkins University
Emmanuel E. Garcia Morales: Johns Hopkins University
Mariana Socal: Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University
Jeromie Ballreich: Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University
Gerard Anderson: Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University

Health Economics Review, 2022, vol. 12, issue 1, 1-12

Abstract: Abstract Background Well-functioning competitive markets are key to controlling generic drug prices. This is important since over 90% of all drugs sold in the US are generics. Recently, there have been examples of large price increases in the generic market. Methods This paper examines price trajectories for generic drugs using a group-based trajectory modelling approach (GBTM). We fit the model using quarterly price information in the IBM MarketScan claims database for the past decade. Results We identify three dominant price trajectories for this period: rapid increase trajectories, slow decline and rapid decline. Most generic drugs show a slow or a rapid decline in price trajectories. However, around 17% of all generic drugs show rapid price increase trajectories. Conclusions As Congress is exploring an excise tax on drugs whose list price increases faster than the rate of inflation, we discuss what drugs would be most likely to be affected by this law.

Keywords: Generic drugs; Group based trajectory models; Mergers and acquisitions; Drug; Prices (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://link.springer.com/10.1186/s13561-022-00384-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:12:y:2022:i:1:d:10.1186_s13561-022-00384-w

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/s13561-022-00384-w

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2022-07-30
Handle: RePEc:spr:hecrev:v:12:y:2022:i:1:d:10.1186_s13561-022-00384-w